Unicharm Co. (OTCMKTS:UNICY - Get Free Report) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 40,800 shares, a decline of 75.2% from the May 15th total of 164,200 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 508,700 shares, the days-to-cover ratio is currently 0.1 days.
Unicharm Price Performance
UNICY traded down $0.09 during midday trading on Friday, hitting $3.98. The stock had a trading volume of 208,956 shares, compared to its average volume of 519,034. The company has a market cap of $11.67 billion, a P/E ratio of 19.90 and a beta of 0.28. The business has a fifty day moving average of $4.26 and a 200 day moving average of $4.23. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.79 and a current ratio of 2.22. Unicharm has a 1 year low of $3.48 and a 1 year high of $8.10.
Unicharm (OTCMKTS:UNICY - Get Free Report) last issued its earnings results on Friday, May 9th. The company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.69 billion. Unicharm had a return on equity of 10.24% and a net margin of 8.67%. As a group, equities analysts forecast that Unicharm will post 0.17 earnings per share for the current fiscal year.
About Unicharm
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
Recommended Stories
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
